WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
This Quarter Return
+3.5%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$3.04B
AUM Growth
–
Cap. Flow
+$3.04B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.92%
Holding
50
New
50
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Adobe
ADBE
|
$161M |
| 2 |
Nike
NKE
|
$159M |
| 3 |
Crown Castle
CCI
|
$158M |
| 4 |
JWN
Nordstrom
JWN
|
$156M |
| 5 |
Johnson & Johnson
JNJ
|
$154M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Consumer Staples | 24.58% |
| 3 | Technology | 24.39% |
| 4 | Consumer Discretionary | 15.35% |
| 5 | Real Estate | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Adobe
ADBE
$151B
| $161M | 5.31% | +3,543,222 | New | +$161M |
|
|
2
Nike
NKE
$114B
| $159M | 5.22% | +2,492,349 | New | +$159M |
|
|
3
Crown Castle
CCI
$43.2B
| $158M | 5.18% | +2,176,464 | New | +$158M |
|
|
JWN
4
DELISTED
Nordstrom
JWN
| $156M | 5.13% | +2,604,333 | New | +$156M |
|
|
5
Johnson & Johnson
JNJ
$427B
| $154M | 5.06% | +1,793,411 | New | +$154M |
|
6
Costco
COST
$418B
| $153M | 5.03% | +1,384,179 | New | +$153M |
|
7
Target
TGT
$43.6B
| $152M | 5.01% | +2,212,613 | New | +$152M |
|
8
Tapestry
TPR
$21.2B
| $152M | 5% | +2,661,398 | New | +$152M |
|
9
Qualcomm
QCOM
$173B
| $152M | 4.99% | +2,482,553 | New | +$152M |
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $151M | 4.97% | +2,449,706 | New | +$151M |
|
|
WFM
11
DELISTED
Whole Foods Market Inc
WFM
| $151M | 4.97% | +2,934,887 | New | +$151M |
|
12
Walt Disney
DIS
$213B
| $150M | 4.93% | +2,375,746 | New | +$150M |
|
13
CVS Health
CVS
$92.8B
| $149M | 4.89% | +2,599,685 | New | +$149M |
|
14
Estee Lauder
EL
$33B
| $146M | 4.8% | +2,219,242 | New | +$146M |
|
|
EMC
15
DELISTED
EMC CORPORATION
EMC
| $146M | 4.79% | +6,162,550 | New | +$146M |
|
16
Mondelez International
MDLZ
$79.5B
| $145M | 4.76% | +5,076,617 | New | +$145M |
|
17
IBM
IBM
$227B
| $145M | 4.75% | +756,377 | New | +$145M |
|
18
Oracle
ORCL
$635B
| $138M | 4.55% | +4,500,164 | New | +$138M |
|
19
Biogen
BIIB
$19.4B
| $79.5M | 2.62% | +369,444 | New | +$79.5M |
|
20
Gilead Sciences
GILD
$140B
| $76.9M | 2.53% | +1,499,924 | New | +$76.9M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $76.2M | 2.51% | +651,187 | New | +$76.2M |
|
22
Amgen
AMGN
$155B
| $76M | 2.5% | +770,388 | New | +$76M |
|
23
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $4.16M | 0.14% | +94,004 | New | +$4.16M |
|
24
Vanguard Extended Market ETF
VXF
$23.9B
| $3.7M | 0.12% | +52,920 | New | +$3.7M |
|
25
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.85B
| $2.05M | 0.07% | +37,455 | New | +$2.05M |
|